Tuberculosis: Extracting Value From a Stagnant Market

Vaccination News Home Page

http://www.datamonitor.com/~85a5b349cdaf46fc8eb23fc69b77fc2f~/healthcare/reports/product_summary.asp?pid=BFHC0500

2 November 2002
 
Contact us - send us your comments or questions Contact Us

Welcome to DatamonitorOver 3000 stories a day, continually updatedA comprehensive source of supplier and customer informationRapid, concise overviews for 10000 companies, 2500 markets and 100 countriesDatamonitors premium products and servicesDatamonitors consulting services
site this sector
 Advanced Search
 Saved Search
All sectors - all products from all our specialist areas
Automotive - Fleet & Retail, Aftermarket and Logistics
Consumer - Food, Drink, Personal Care, Retail, Ingredient and Packaging
Energy - Power, Utilities, Fuel Retailing and LPG
Financial Services - Banking, Investment and Insurance
Healthcare - Cardiovascular disease, CNS disorders, Immune disorders and inflammation, Infectious diseases, and Oncology
Technology - Internet Economy; Business eInfrastructure; Customer Facing Technology, CRM and Network Infrastructure
View library - view your library of products
Edit profile - change your profile
About Datamonitor - what puts us at the forefront of global business intelligence
About Datamonitor - what puts us at the forefront of global business intelligence
View basket - view all purchases Mail a friend - let a friend or colleague know about this
Contact us - send us your comments or questions Help - online help guide to www.datamonitor.com Legal - click here to read our Privacy Policy
CONTACT HELP LEGAL
 
  
  
Reports & Services > Healthcare > Infectious Diseases >
Report Tuberculosis: Extracting Value From a Stagnant Market
 
Brief No.
BFHC0500		 Published
30 Sep 2002
Buy Now   $ 1,500
Product BrochureSummary of Contents
Introduction
The TB treatment and prophylaxis market has experienced limited growth and activity over the last 40 years, as companies have perceived TB as primarily a "poor disease". However, the market now looks to hold greater potential, with rising incidence in the US, and improved diagnostics creating a renewed demand for both vaccination and therapeutics.


 

Scope of this report
  • Overview of TB pathology and epidemiology
  • Review of current TB diagnostic technologies and areas of unmet need in the diagnostics market
  • Assessment of current TB treatment, highlighting areas of unmet need and potential market opportunity
  • Analysis of the prophylaxis market providing strategic insight into clinical trial design and strategies for market penetration


    •  

    Report Highlights
    There are three key areas within the TB market with high levels of unmet need, namely diagnostics, therapeutics, and prophylaxis.
    TB vaccines with higher efficacy and longevity will help to persuade governments in the developed world to reconsider including TB prophylaxis in immunization schedules.
    Improvements in the rapidity and accuracy of diagnostic technologies will drive patient potential and market growth. The development of second line treatment options for resistant infection will increase the value of the TB treatment market.


     

    Key reasons to buy this report
  • Identify the areas of the TB market which offer the highest potential for new market entrants
  • Understand the changing competitive dynamics in the TB market
  • Identify the key epidemiological trends for TB in the major markets
    		•

    Welcome!
    If you have an account please
    Log in

    otherwise Register with us

     


    Ways to buy from Datamonitor
    Any questions about Datamonitor or our services?
    Related Research
     
    Brief Tuberculosis: A Clinical Timebomb

     
    Brief Systemic Antifungal Treatment - The Impact of the Latestage Pipeline

     
    Report Strategic Perspectives: Opportunistic Infections in HIV - Will HAART Be Enough?

     


     

    Vaccination News Home Page

    ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.